15-Lipoxygenase-1 Is Involved in the Effects of Atorvastatin on Endothelial Dysfunction

Table 4

Numbers in results.

Figure 4	Group	Mean ± SD
(a) VCAM-1	ox-LDL	1.249 ± 0.111
	ox-LDL + PD146176	0.498 ± 0.056
(a) ICAM-1	ox-LDL	2.012 ± 0.362
	ox-LDL + PD146176	1.267 ± 0.362
(b) VCAM-1	ox-LDL + Lv-GFP	1.118 ± 0.078
	ox-LDL + Lv-shALOX15	0.916 ± 0.016
(b) ICAM-1	ox-LDL + Lv-GFP	1.437 ± 0.147
	ox-LDL + Lv-shALOX15	0.632 ± 0.056
(c) p-AKT	ox-LDL	0.465 ± 0.201
	ox-LDL + PD146176	0.814 ± 0.134
(c) p-eNOS	ox-LDL	0.428 ± 0.145
	ox-LDL + PD146176	0.711 ± 0.203
(d) p-AKT	ox-LDL + Lv-GFP	0.550 ± 0.058
(d) p-eNOS	ox-LDL + Lv-shALOX15	1.113 ± 0.289
	ox-LDL + Lv-GFP	0.422 ± 0.174
	ox-LDL + Lv-shALOX15	0.953 ± 0.177